In summary, we report and present biophysical and pharmacological analysis of a novel de novo SCN5A mutation that was discovered in a newborn diagnosed with severe LQTS providing additional evidence of the importance of Na+ channel mutations in inherited arrhythmias in newborns. The gene discussed is SCN5A; the disease is cardiac arrhythmia.